Figure 2.
MRS screening and functional analysis. (A) Expression level of DEGs in metastatic and non-metastatic groups of TARGET cohort; (B) expression level of DEGs in metastasis and non-metastatic groups of the GSE21257 cohort; (C) expression level of DEGs in metastatic and non-metastatic groups of GSE32981 cohort; (D) GSE49003 cohort transfer and expression levels of non-metastatic cell line DEGs.